|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 34.51 USD | +5.31% |
|
-0.58% | +223.43% |
| 08-21 | Needham Initiates Faeth Therapeutics at Buy With $56 Price Target | MT |
| 08-17 | Faeth Therapeutics Shares Rise on FDA Fast-Track Designation for Cancer Treatment | DJ |
| Market Cap | 892M 769M 724M 660M 1.24B 84.66B 1.25B 8.58B 3.33B 43.04B 3.35B 3.28B 143B | P/E 2026 * |
-1.42x | P/E 2027 * | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 892M 769M 724M 660M 1.24B 84.66B 1.25B 8.58B 3.33B 43.04B 3.35B 3.28B 143B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +5.31% | ||
| 1 week | -0.58% | ||
| Current month | +5.31% | ||
| 1 month | +26.69% | ||
| 3 months | +63.25% | ||
| 6 months | +13.15% | ||
| Current year | +223.43% |
| 1 week | 31.75 |  | 35.24 |
| 1 month | 23.12 | | 36 |
| Current year | 8.37 | | 37.9 |
| 1 year | 7.45 | | 37.9 |
| 3 years | 5 | | 38.8 |
| 5 years | 5 | | 247.4 |
| 10 years | 5 | | 530 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anand Parikh
CEO | Chief Executive Officer | 40 | 2026-06-12 |
Brian Stephenson
DFI | Director of Finance/CFO | 45 | 2026-06-12 |
Deepak Tiwari
COO | Chief Operating Officer | - | 2026-08-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Bob Holmen
CHM | Chairman | 62 | 2024-12-31 |
Thomas Ricks
BRD | Director/Board Member | 72 | 2014-12-31 |
Kristian Humer
BRD | Director/Board Member | 51 | 2021-07-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Free | Chief Executive Officer | 398,018 | 1.5440% | ||
| 7/21/26 | Free | Controller/Auditor | 30,824 | 0.1196% | ||
| 7/1/26 | Buy | Chief Financial Officer | 5,000 | 0.0194% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.31% | -0.58% | +313.05% | +72.55% | 847M | |
| -0.25% | -0.92% | +49.47% | +89.45% | 68.13B | |
| +1.21% | +2.55% | +46.72% | +90.66% | 63.6B | |
| +1.31% | +1.81% | +49.04% | +12.07% | 25.57B | |
| -0.25% | -1.99% | -10.72% | +455.09% | 26.6B | |
| +0.33% | -9.64% | +1.95% | -15.70% | 25.52B | |
| -6.09% | -11.19% | +224.80% | +351.08% | 18.23B | |
| +1.18% | +1.66% | +35.20% | -18.67% | 19.69B | |
| -1.49% | -6.35% | +7.84% | +540.26% | 15.16B | |
| +4.12% | +4.29% | +52.03% | +154.09% | 13.54B | |
| Average | +0.54% | -4.02% | +76.94% | +173.09% | 27.69B | |
| Weighted average by Cap. | +0.16% | -2.87% | +47.82% | +145.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -230M -199M -187M -170M -320M -21.86B -322M -2.21B -860M -11.11B -865M -846M -36.88B | -110M -95.3M -89.67M -81.74M -154M -10.49B -155M -1.06B -413M -5.33B -415M -406M -17.69B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$34.51 | +5.31% | 276,713 |
| 26-08-31 | US$32.77 | -3.16% | 173,126 |
| 26-08-28 | US$33.84 | +0.30% | 288,295 |
| 26-08-27 | US$33.74 | +2.34% | 198,586 |
| 26-08-26 | US$32.97 | -4.49% | 140,919 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FTH Stock
Select your edition
All financial news and data tailored to specific country editions
